(roboshan): - - An acquisition down the line that might make sense would be a suitable CGMP rated manufacturing facility (in Australia) - -
Look no further than here for a cGMP approved manufacture: http://www.pharmasynth.com.au/
PharmaSynth was recently spun off by Progen for a purpose.
Progen’s future strategic direction is in tatters and the BOD is in turmoil. They may be very interested in a reasonable offer for PharmaSynth.
PharmaSynth provides the following pharmaceutical services: •Process development •Scale up and technology transfer •cGMP manufacture •Biopharmaceutical manufacture from bacterial or yeast fermentation •Synthetic small molecule manufacture •Pilot scale to commercial •Human and veterinary manufacture •Stability testing •Analytical services •Regulatory support •TGA / APVMA / OGTR inspected and approved
CST Price at posting:
$2.00 Sentiment: None Disclosure: Not Held
